News

14 January 2009

 

Riber grew 13% in 2008, driven by production MBE reactors

Riber S.A. of Bezons, France, which manufactures molecular beam epitaxy (MBE) systems as well as evaporation sources and effusion cells, says that, for 2008, its consolidated revenues totaled €19.2m, up 13% on 2007’s €17m. This follows sales of just €5.2m in first-half 2008 (in late September, Riber acquired the Oxford Instruments Plasma Technology’s MBE business, whose average turnover in recent years has been about €1.2m).

In 2008 an 11% decline in European revenue was offset by strong growth in Asia (up 33%) and the USA (up 175%). Nevertheless, Europe still represented 47% of total revenue, Asia 42%, and the USA 11%.

In line with guidance, the components and after-sales-service business reported strong growth of 37% from €4.3m in 2007 to €5.9m in 2008.

Machine revenues grew by 5% to €13.3m (16 machines, compared to 12 in 2007). In particular, production machine revenue grew 17% to €5.2m, whereas research machine revenue was stable at €8.1m.

In 2009, the component and after-sales-service businesses should continue to grow, due in particular to the acquisition of Oxford Instruments Plasma Technology’s MBE business and the launch of new products, notably for the organic LED screen and copper indium gallium diselenide (CIGS) solar cells markets.

Riber adds that, regarding research machines, the market should remain strong. However, the outlook for production machines remains uncertain during the current economic climate.

Full 2008 financial results will be reported on 11 March.

See related items:

Riber buys OIPT’s MBE business

Riber confident of €18m sales forecast

Riber doubles sales year-on-year to €5.1m in first-half 2008

Riber reports tough 2007, but forecasts better year ahead

Search: Riber MBE

Visit: www.riber.com